NCI-H508（人結(jié)直腸腺癌）
CBP60795
詢 價(jià)
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
| I. General information | |
| Synonyms: | NCI-H508 |
| Background: | This line was derived from a metastasis to the abdominal wall obtained from a patient after treatment with 5-fluorouracil. |
| Species: | Homo sapiens, human |
| Tissue: | cecum |
| Disease: | colorectal adenocarcinoma |
| Gender: | male， 55 years， Caucasian |
| Morphology: | epithelial |
| Growth Mode: | floating aggregates of round cells with some attached cells |
| DNA Profile: | Amelogenin: X CSF1PO: 11,12 D13S317: 8,12 D16S539: 12 D5S818: 12 D7S820: 8,12 THO1: 9,9.3 TPOX: 8,11 vWA: 15,16 Our Cell Line Authentication Service |
| Culture Medium: |
RPMI-1640+10%FBS NCI-H508完全培養(yǎng)基，# CBP60795M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Antigen Expression: | Blood type A; Rh+; CA19-9 antigen |
| Genes Expressed: | carcinoembryonic antigen (CEA), 1709 ng/mL per 106 cells per 10 days |
| Cellular Products: | carcinoembryonic antigen (CEA), 1709 ng/mL per 106 cells per 10 days |
| Tumor Formation: | Yes, in nude mice Tumors developed within 21 days at 100% frequency (5/5) in nude mice inoculated subcutaneously with 107 cells |
| Comments: | The cells contain Dopa decarboxylase, CA19-9 antigen and CEA but do not express the TAG-72 antigen. For more information, please contact us (4008-750-250). |
